TY  - GEN
AU  - Liu,Chun-Yu
AU  - Huang,Tzu-Ting
AU  - Huang,Chun-Teng
AU  - Hu,Ming-Hung
AU  - Wang,Duen-Shian
AU  - Wang,Wan-Lun
AU  - Tsai,Wen-Chun
AU  - Lee,Chia-Han
AU  - Lau,Ka-Yi
AU  - Yang,Hsiu-Ping
AU  - Chen,Ming-Huang
AU  - Shiau,Chung-Wai
AU  - Tseng,Ling-Ming
AU  - Chen,Kuen-Feng
TI  - EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells
SN  - 1879-0852
PY  - 2017///0809
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Autoantigens
KW  - genetics
KW  - Disease Models, Animal
KW  - ErbB Receptors
KW  - metabolism
KW  - Erlotinib Hydrochloride
KW  - Heterografts
KW  - Humans
KW  - Intracellular Signaling Peptides and Proteins
KW  - Membrane Proteins
KW  - Mice
KW  - Mice, Nude
KW  - RNA, Messenger
KW  - Signal Transduction
KW  - Triple Negative Breast Neoplasms
KW  - drug therapy
KW  - Tumor Cells, Cultured
KW  - ets-Domain Protein Elk-1
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.ejca.2016.11.012
ER  -